4.6 Article

Cutting Edge: Murine Mast Cells Rapidly Modulate Metabolic Pathways Essential for Distinct Effector Functions

期刊

JOURNAL OF IMMUNOLOGY
卷 198, 期 2, 页码 640-644

出版社

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1601150

关键词

-

资金

  1. Public Health Service Grant [R56AI067544]
  2. Sidney Kimmel Foundation for Cancer Research Grant [SKF-015-039]

向作者/读者索取更多资源

There is growing appreciation that cellular metabolic and bioenergetic pathways do not play merely passive roles in activated leukocytes. Rather, metabolism has important roles in controlling cellular activation, differentiation, survival, and effector function. Much of this work has been performed in T cells; however, there is still very little information regarding mast cell metabolic reprogramming and its effect on cellular function. Mast cells perform important barrier functions and help control type 2 immune responses. In this study we show that murine bone marrow-derived mast cells rapidly alter their metabolism in response to stimulation through the Fc epsilon RI. We also demonstrate that specific metabolic pathways appear to be differentially required for the control of mast cell function. Manipulation of metabolic pathways may represent a novel point for the manipulation of mast cell activation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

A Murine Model of X-Linked Moesin-Associated Immunodeficiency (X-MAID) Reveals Defects in T Cell Homeostasis and Migration

Lyndsay Avery, Tanner F. Robertson, Christine F. Wu, Nathan H. Roy, Samuel D. Chauvin, Eric Perkey, Ashley Vanderbeck, Ivan Maillard, Janis K. Burkhardt

Summary: X-MAID is a primary immunodeficiency disease characterized by severe lymphopenia and recurrent infections. Using a mouse model, researchers found that the disease is caused by a mutation in the protein moesin. This model provides valuable insights into the complexity of immunodeficiency and the role of the actin cortex in lymphocyte function.

FRONTIERS IN IMMUNOLOGY (2022)

Article Oncology

Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

Andrew W. Hahn, Ashley Menk, Dayana B. Rivadeneira, Ryan C. Augustin, Mingchu Xu, Jun Li, Xiaogang Wu, Aditya K. Mishra, Tuba N. Gide, Camelia Quek, Yan Zang, Christine N. Spencer, Alexander M. Menzies, Carrie R. Daniel, Courtney W. Hudgens, Theodore Nowicki, Lauren E. Haydu, M. A. Wadud Khan, Vancheswaran Gopalakrishnan, Elizabeth M. Burton, Jared Malke, Julie M. Simon, Chantale Bernatchez, Nagireddy Putluri, Scott E. Woodman, Y. N. Vashisht Gopal, Renato Guerrieri, Grant M. Fischer, Jian Wang, Khalida M. Wani, John F. Thompson, Jeffrey E. Lee, Patrick Hwu, Nadim Ajami, Jeffrey E. Gershenwald, Georgina Long, Richard A. Scolyer, Michael T. Tetzlaff, Alexander J. Lazar, Dirk Schadendorf, Jennifer A. Wargo, John M. Kirkwood, Ralph J. DeBerardinis, Han Liang, Andrew Futreal, Jianhua Zhang, James S. Wilmott, Weiyi Peng, Michael A. Davies, Greg M. Delgoffe, Yana G. Najjar, Jennifer L. McQuade

Summary: This study investigated the association between body mass index (BMI) and tumor or microbiome characteristics in patients with metastatic melanoma. The findings suggest that the host metabolic phenotype influences melanoma metabolism and may explain the improved outcomes observed in overweight/obese patients treated with immune checkpoint inhibitors and targeted therapies.

CLINICAL CANCER RESEARCH (2023)

Article Immunology

Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity

Paolo D. A. Vignali, Kristin DePeaux, McLane J. J. Watson, Chenxian Ye, B. Rhodes Ford, Konstantinos Lontos, Nicole K. K. McGaa, Nicole E. E. Scharping, Ashley V. V. Menk, Simon C. C. Robson, Amanda C. C. Poholek, Dayana B. B. Rivadeneira, Greg M. M. Delgoffe

Summary: CD8(+) T cells play a crucial role in cancer cell elimination. Exhaustion, a hypofunctional state, can be induced in these cells by factors in the tumor microenvironment (TME). Highly exhausted T (tT(ex)) cells, resistant to checkpoint blockade immunotherapy, resemble CD4(+)Foxp3(+) regulatory T cells and suppress T cell proliferation through CD39-generated immunosuppressive adenosine. Restricting CD39 in endogenous CD8(+) T cells slows tumor progression, improves immunotherapy response, and enhances infiltration of tumor-specific T cells. Induced by tumor hypoxia, CD39 expression on tT(ex) cells can be mitigated to reduce their suppressive effects. Hence, targeting or eliminating tT(ex) cells in the TME could enhance immunotherapy efficacy.

NATURE IMMUNOLOGY (2023)

Article Oncology

The effect of opioids on the efficacy of immunotherapy in recurrent/ metastatic squamous cell carcinoma of the head and neck

Nicole N. Scheff, Marci L. Nilsen, Jinhong Li, Alexandria L. Harris, Rajesh Acharya, Andrew Swartz, Ronan W. Hsieh, Jennifer L. Anderson, Robert L. Ferris, Ashley V. Menk, Greg M. Delgoffe, Dan P. Zandberg

Summary: This study evaluated the impact of opioids on the efficacy of immunotherapy in recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) patients. The results showed that higher opioid dosages were associated with lower progression-free survival and overall survival, as well as lower CD8+ T cell counts in the tumor microenvironment.

ORAL ONCOLOGY (2023)

Article Oncology

Mesothelin-targeting T cells bearing a novel T cell receptor fusion construct (TRuC) exhibit potent antitumor efficacy against solid tumors

Jian Ding, Sarah Guyette, Brett Schrand, Jessica Geirut, Holly Horton, Guangwu Guo, Greg Delgoffe, Ashley Menk, Patrick A. Baeuerle, Robert Hofmeister, Robert Tighe

Summary: TRuC-T cells utilize all signaling subunits of the TCR to activate T cells and effectively kill MSLN+ tumor cells, showing comparable efficacy to MSLN-targeted CAR-T cells. However, TRuC-T cells exhibit faster tumor rejection kinetics, earlier intratumoral accumulation, and signs of activation. Metabolic profiling also indicates that TRuC-T cells have lower glycolytic activity and higher mitochondrial metabolism than CAR-T cells. These findings highlight TRuC-T cells as a promising cell therapy for MSLN-expressing cancers.

ONCOIMMUNOLOGY (2023)

Article Oncology

Metabolic reprogramming via an engineered PGC-1α improves human chimeric antigen receptor T-cell therapy against solid tumors

Konstantinos Lontos, Yiyang Wang, Supriya K. Joshi, Andrew T. Frisch, McLane J. Watson, Alok Kumar, Ashley Menk, Yupeng Wang, Rachel Cumberland, Jason Lohmueller, Esteban Carrizosa, Benjamin Boyerinas, Greg M. Delgoffe

Summary: This study demonstrates that an engineered version of the inhibitory transcription factor PGC-1 alpha can metabolically reprogram human CAR-T cells, resulting in improved in vivo efficacy for the treatment of solid tumors. In contrast, a truncated version of PGC-1 alpha, NT-PGC-1 alpha, did not improve the in vivo outcomes.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2023)

Article Oncology

Metformin is associated with improved clinical outcomes in patients with melanoma: a retrospective, multi-institutional study

Ryan C. Augustin, Ziyu Huang, Fei Ding, Shuyan Zhai, Jennifer McArdle, Anthony Santisi, Michael Davis, Cindy Sander, Diwakar Davar, John M. Kirkwood, Greg M. Delgoffe, Allison Betof Warner, Yana G. Najjar

Summary: In this study, it was found that metformin treatment in diabetic melanoma patients is associated with lower recurrence rates, higher survival rates, and reduced incidence of brain metastases.

FRONTIERS IN ONCOLOGY (2023)

Article Medicine, Research & Experimental

The schedule of ATR inhibitor AZD6738 can potentiate or abolish antitumor immune responses to radiotherapy

Frank P. Vendetti, Pinakin Pandya, David A. Clump, Sandra Schamus-Haynes, Meysam Tavakoli, Maria diMayorca, Naveed M. Islam, Jina Chang, Greg M. Delgoffe, Jan H. Beumer, Christopher J. Bakkenist

Summary: Inhibitors of the ATR kinase can enhance the killing of tumor cells by DNA replication fork-targeting chemotherapies but also affect rapidly proliferating immune cells. Combining ATR inhibitor and radiotherapy can stimulate CD8+ T cell-dependent antitumor responses. The optimal schedule of ATR inhibitor and radiotherapy is determined by the duration of ATR inhibitor treatment, which affects the expansion of tumor antigen-specific CD8+ T cells.

JCI INSIGHT (2023)

Article Immunology

An oncolytic virus-delivered TGFβ inhibitor overcomes the immunosuppressive tumor microenvironment

Kristin Depeaux, Dayana B. Rivadeneira, Konstantinos Lontos, Victoria G. Dean, William G. Gunn, McLane J. Watson, Tianhong Yao, Drew Wilfahrt, Cynthia Hinck, Lukasz Wieteska, Stephen H. Thorne, Andrew P. Hinck, Greg M. Delgoffe

Summary: Oncolytic viruses can induce tumor lysis and activate the tumor microenvironment, but they do not relieve immunosuppressive signals. Engineering oncolytic vaccinia virus to express a potent TGF beta R inhibitor can neutralize TGF beta locally, increase fragility of Treg cells, and achieve a superior therapeutic response.

JOURNAL OF EXPERIMENTAL MEDICINE (2023)

Article Hematology

Complementary HLH susceptibility factors converge on CD8 T-cell hyperactivation

Emily Landy, Jemy Varghese, Vinh Dang, Andrea Szymczak-Workman, Lawrence P. Kane, Scott W. Canna

Summary: Hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS) are life-threatening hyperinflammatory syndromes. Understanding the synergistic effect of susceptibility factors can reveal key pathomechanisms in the activation of CD8 T cells.

BLOOD ADVANCES (2023)

Article Gastroenterology & Hepatology

Excess Dietary Sugar Alters Colonocyte Metabolism and Impairs the Proliferative Response to Damage

Ansen H. P. Burr, Junyi Ji, Kadir Ozler, Heather L. Mentrup, Onur Eskiocak, Brian Yueh, Rachel Cumberland, Ashley V. Menk, Natalie Rittenhouse, Chris W. Marshall, Pailin Chiaranunt, Xiaoyi Zhang, Lauren Mullinax, Abigail Overacre-Delgoffe, Vaughn S. Cooper, Amanda C. Poholek, Greg M. Delgoffe, Kevin P. Mollen, Semir Beyaz, Timothy W. Hand

Summary: This study revealed the direct impact of high-sugar diet on the function of colonic stem cells and transit-amplifying cells using 3-dimensional colonoids and a mouse model of colon damage and repair. The findings showed that high-sugar conditions restrict colonoid development, reduce the expression of proliferative genes, ATP levels, and lead to pyruvate accumulation. Treatment with dichloroacetate restored colonoid growth. Moreover, a high-sugar diet combined with dextran sodium sulfate treatment resulted in severe irreparable colon damage. ISC gene expression was reduced, proliferative potential was impeded, and glycolytic potential was increased without a corresponding increase in aerobic respiration.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Microbiology

Interferon signaling drives epithelial metabolic reprogramming to promote secondary bacterial infection

Grace P. Carreno-Florez, Brian R. Kocak, Matthew R. Hendricks, Jeffrey A. Melvin, Katrina B. Mar, Jessica Kosanovich, Rachel L. Cumberland, Greg M. Delgoffe, Sruti Shiva, Kerry M. Empey, John W. Schoggins, Jennifer M. Bomberger

Summary: Viral infections can make the host susceptible to secondary bacterial infections, and this study identified specific interferon-stimulated genes (ISGs) that promote Pseudomonas aeruginosa infection. The mechanism of action was also investigated, revealing the role of hexokinase 2 (HK2) in mediating metabolic changes and lactate secretion to enhance bacterial infection. These findings improve our understanding of how the host immune response can lead to viral-bacterial co-infection.

PLOS PATHOGENS (2023)

Meeting Abstract Oncology

Polyamine transport inhibition with AMXT-1501 synergizes with cisplatin in HNSCC

A. Yassin-Kassab, R. A. Harbison, N. Wang, M. Burns, G. Delgoffe, U. Duvvuri

EUROPEAN JOURNAL OF CANCER (2022)

Meeting Abstract Oncology

The effect of opioids on the efficacy of immunotherapy in recurrent/metastatic squamous cell carcinoma of the head and neck (R/M HNSCC).

Nicole N. Scheff, Marci Lee Nilsen, Jinhong Li, Alexandria L. Harris, Andrew Swartz, Ronan Wenhan Hsieh, Jennifer Lynn Anderson, Robert L. Ferris, Ashley Menk, Greg M. Delgoffe, Dan Paul Zandberg

JOURNAL OF CLINICAL ONCOLOGY (2022)

Review Medicine, Research & Experimental

Fighting in a wasteland: deleterious metabolites and antitumor immunity

McLane J. Watson, Greg M. Delgoffe

Summary: The tumor microenvironment depletes essential nutrients and produces toxic metabolites that shape immune cell function and impact cancer immunotherapy.

JOURNAL OF CLINICAL INVESTIGATION (2022)

暂无数据